MedPath

DIGOXIN

These highlights do not include all the information needed to use DIGOXIN safely and effectively. See full prescribing information for DIGOXIN. DIGOXIN (digoxin) tablets, for oral use Initial U.S. Approval: 1954

Approved
Approval ID

415b168c-121f-2777-e054-00144ff88e88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 22, 2020

Manufacturers
FDA

NuCare Pharmaceuticals, Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIGOXIN

PRODUCT DETAILS

NDC Product Code66267-443
Application NumberNDA020405
Marketing CategoryC73605
Route of AdministrationORAL
Effective DateJanuary 22, 2020
Generic NameDIGOXIN

INGREDIENTS (7)

STARCH, POTATOInactive
Code: 8I089SAH3T
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
DIGOXINActive
Quantity: 0.125 mg in 1 1
Code: 73K4184T59
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIGOXIN - FDA Drug Approval Details